Adam Kesingland
Overview
Explore the profile of Adam Kesingland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dziadulewicz E, Bevan S, Brain C, Coote P, Culshaw A, Davis A, et al.
J Med Chem
. 2007 Jul;
50(16):3851-6.
PMID: 17630726
Selective activation of peripheral cannabinoid CB1 receptors has the potential to become a valuable therapy for chronic pain conditions as long as central nervous system effects are attenuated. A new...
2.
Fox A, Gentry C, Patel S, Kesingland A, Bevan S
Pain
. 2003 Sep;
105(1-2):355-62.
PMID: 14499454
Anti-epileptic drugs (AEDs) are increasingly used for the treatment of neuropathic pain. Oxcarbazepine is a recently introduced AED that is effective in treating epilepsy and has an improved side-effect profile...
3.
Walker K, Medhurst S, Kidd B, Glatt M, Bowes M, Patel S, et al.
Pain
. 2002 Dec;
100(3):219-229.
PMID: 12467993
Inoculation of syngeneic MRMT-1 mammary tumour cells into one tibia of female rats produced tumour growth within the bone associated with a reduction in bone mineral density (BMD) and bone...
4.
Patel S, Naeem S, Kesingland A, Froestl W, Capogna M, Urban L, et al.
Pain
. 2001 Feb;
90(3):217-226.
PMID: 11207393
We have examined the effects of a novel GABA(B) agonist, CGP35024, in models of chronic neuropathic (partial sciatic ligation) and inflammatory (Freund's complete adjuvant) pain in the rat, and its...